Dr. Kavanagh is Senior Scientific Advisor, Gene Therapy, Vaccines, and Biologics at WCG, working with clinical trial sponsors and sites to promote safe, efficient, and compliant clinical trial operations, with a focus on human gene transfer research. Prior to joining WCG, Dr. Kavanagh was Institutional Biosafety Committee Vice Chair at Harvard Medical School and the Massachusetts General Hospital, where he was co-chair of a Phase I clinical trial of an mRNA-based therapeutic vaccine. He is also certified in regulatory affairs for drugs, biologics, and devices (RAC-US) by the Regulatory Affairs Professional Society.